marinuspharma.com (MRNS) - Quarterly Revenue Growth

Symbol and logo of brand Marinus Pharmaceuticals, Inc. (MRNS)

Marinus Pharmaceuticals (MRNS) delegates the production of anticonvulsants to external contractors, while its own packaging facilities are currently being modernized. The strategy focuses on orphan neurology, targeting the extensive market for pediatric genetic pathology therapies. Revenue is based on the sale of patented drugs to clinics. The quarterly revenue growth rate demonstrates the business's financial dynamics, where 16.70 determines the current status of the parameter.

MRNS (Marinus) Quarterly Revenue Growth history from 07/04/2022 to 02/22/2025

MRNS (Marinus Pharmaceuticals, Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:
- cash and cash flow data:
Analysis of all company metrics:marinuspharma.com (MRNS)
Mass-produced product of marinuspharma.com

The implementation of robotic molecule screening and clinical data analysis automation at Marinus Pharmaceuticals (MRNS) directly impacts sales scalability. This trend is reflected in the quarterly revenue growth chart, which measures income growth rates relative to economic liquidity, allowing investors to timely identify a business cooling phase and avoid entering the asset before expansion rates decline.

Competitor analysis

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|ACIU: Quarterly Revenue Growth|VYGR - Quarterly Sales Growth Rate|Revenue Growth QoQ Neumora Therapeutics, Inc.|Sales Growth QoQ SCLX (Scilex)|Quarterly Sales Growth TVGN (Tevogen Bio)|Quarterly Revenue Growth Alpha Cognition Inc (ACOG)|Quarterly Revenue Growth CGTX (cogrx.com)|Quarterly Sales Growth Rate Inhibikase Pharma (IKT)|SAVA: Quarterly Sales Growth|Quarterly Sales Growth Rate Assertio ASRT|COYA (coyatherapeutics.com) - Quarterly Sales Growth|Sales Growth QoQ VTGN|OVID (Ovid Therapeutics) - Quarterly Revenue Growth|Acumen Pharmaceuticals, Inc (ABOS) - Quarterly Sales Growth Rate|Revenue Growth QoQ CervoMed, Inc. (CRVO)|ATHE - Quarterly Revenue Growth Rate|Quarterly Revenue Growth CLNN (Clene Inc.)|Quarterly Sales Growth Rate PepGen Inc. (PEPG)|JUNS - Revenue Growth QoQ|Quarterly Revenue Growth Rate Relmada Corp|ANVS (Annovis Bio, Inc.) - Quarterly Sales Growth|Grace Tx (GRCE) - Quarterly Revenue Growth|Quarterly Sales Growth AIFF|Quarterly Revenue Growth anewmeds.com|Revenue Growth QoQ NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Quarterly Revenue Increase|MetaVia - Quarterly Sales Growth|NRXS: Sales Growth QoQ|Helius Medical Technologies, Inc. - Quarterly Revenue Growth|PASG: Revenue Growth QoQ|Neuphoria (NEUP) - Revenue Growth QoQ|Minerva Neurosciences - Quarterly Revenue Increase|ATHA (Athira Pharma, Inc.) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate addextherapeutics.com ADXN|Quarterly Sales Growth ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Quarterly Revenue Increase|Quarterly Revenue Growth PTIX (Protagenic)|Quarterly Revenue Growth pasitheaclinics.com KTTA|CRGT - Revenue Growth QoQ|Quarterly Revenue Increase ATXI (Avenue Therapeutics)|BCLI: Quarterly Revenue Growth|Cara Therapeutics - Quarterly Revenue Increase|Revenue Growth QoQ Chromocell Therapeutics Corporation|Quarterly Revenue Growth Eliem Therapeutics Inc.|Revenue Growth QoQ Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ